IL203051A - Use of alpha-ketoglutarate for the preparation of medicaments - Google Patents

Use of alpha-ketoglutarate for the preparation of medicaments

Info

Publication number
IL203051A
IL203051A IL203051A IL20305109A IL203051A IL 203051 A IL203051 A IL 203051A IL 203051 A IL203051 A IL 203051A IL 20305109 A IL20305109 A IL 20305109A IL 203051 A IL203051 A IL 203051A
Authority
IL
Israel
Prior art keywords
ketoglutarate
medicaments
alpha
preparation
Prior art date
Application number
IL203051A
Other languages
Hebrew (he)
Original Assignee
Danuta Kruszewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07460015A external-priority patent/EP1917959B1/en
Application filed by Danuta Kruszewska filed Critical Danuta Kruszewska
Publication of IL203051A publication Critical patent/IL203051A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL203051A 2007-07-03 2009-12-30 Use of alpha-ketoglutarate for the preparation of medicaments IL203051A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07460015A EP1917959B1 (en) 2006-07-03 2007-07-03 New medical use of alfa-ketoglutarate
PCT/PL2007/000086 WO2009005379A1 (en) 2007-07-03 2007-12-31 New medical applications of alpha-ketoglutarate

Publications (1)

Publication Number Publication Date
IL203051A true IL203051A (en) 2014-07-31

Family

ID=39322797

Family Applications (1)

Application Number Title Priority Date Filing Date
IL203051A IL203051A (en) 2007-07-03 2009-12-30 Use of alpha-ketoglutarate for the preparation of medicaments

Country Status (5)

Country Link
JP (2) JP5518702B2 (en)
KR (2) KR20150003908A (en)
CN (2) CN102014888A (en)
IL (1) IL203051A (en)
WO (1) WO2009005379A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102132997B1 (en) 2011-10-11 2020-07-14 메디뮨 엘엘씨 Cd40l-specific tn3-derived scaffolds and methods of use thereof
CN103168972A (en) * 2013-04-19 2013-06-26 中国水产科学研究院黑龙江水产研究所 Feed capable of enhancing growth performance and protein deposition of carp
EP3086770B1 (en) * 2013-12-27 2019-10-30 Colgate-Palmolive Company Prebiotic oral care compositions containing carboxylic acids
CN104257643B (en) * 2014-09-15 2016-09-21 华南理工大学 Lithodialysis agent of urinary system phosphatic calculus based on α-ketoglutaric acid and preparation method thereof
CN104721176B (en) * 2015-02-02 2018-07-10 中山大学 Application of the α-ketoglutaric acid in terms of sensibility of bacteria on antibiotic is improved
US10683340B2 (en) 2015-03-12 2020-06-16 Medimmune, Llc Method of purifying albumin-fusion proteins
CN105325731A (en) * 2015-12-07 2016-02-17 湖南农业大学 Application of alpha-ketoglutarate serving as feed additive and corresponding feed
CN105475230B (en) * 2015-12-17 2018-04-20 中国农业大学 A kind of method for improving above the average age for marriage animal reproduction power
LU100900B1 (en) * 2018-08-10 2020-02-17 Thomas Melchior Homann COMPOUNDS FOR MODULATING A-KETOGLUTARIC ACID (2KG) -DEPENDENT OXYGENASES
CA3124725A1 (en) * 2018-10-10 2020-04-16 Servatus Ltd Methods of treatment of inflammatory conditions and associated infections
PE20220018A1 (en) * 2019-06-14 2022-01-11 Cj Cheiljedang Corp COMPOSITION TO PREVENT, TREAT OR IMPROVE GASTROINTESTINAL DISEASES THAT COMPRISES A STRAIN OF THE GENUS CORYNEBACTERIUM AND CULTIVATION OF THE SAME
WO2021136765A1 (en) * 2019-12-30 2021-07-08 Devicare, S.L. Compositions for clinical complications associated to devices implanted in the urinary tract
CN111067885A (en) * 2020-02-20 2020-04-28 杨益文 Medicine for eliminating helicobacter pylori and treating gastric ulcer and duodenal ulcer
CN111820330A (en) * 2020-07-17 2020-10-27 禹城保立康生物饲料有限公司 Sow feed for improving growth of suckling piglets
CN113337436A (en) * 2021-06-09 2021-09-03 中国科学院新疆生态与地理研究所 Urea decomposing bacteria and breeding method and application thereof
CN113995054A (en) * 2021-11-02 2022-02-01 中国科学院亚热带农业生态研究所 Application of ornithine-alpha-ketoglutaric acid in preparation of feed for promoting growth of nursery pigs
CN115340313B (en) * 2022-01-17 2023-04-18 浙江理工大学 Method for reinforcing recycled aggregate by physical compound microbial technology

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919855B1 (en) * 1970-10-06 1974-05-21
SE9303691D0 (en) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
JP2002529545A (en) * 1998-11-06 2002-09-10 ユニベルシテ ドゥ モントリオール Improved germicidal and non-sterile solutions for removing biofilms
JP4533496B2 (en) * 2000-03-15 2010-09-01 三菱重工業株式会社 Fuel production method from biomass
EP1184443A1 (en) * 2000-09-04 2002-03-06 Biofuel B.V. Process for the production of liquid fuels from biomass
FR2822704B1 (en) * 2001-03-29 2005-02-18 Chiesi Sa SALTS OF KETOACIDES AND GASTRORESISTANT AMINO ACIDS AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS
SE0200256D0 (en) * 2001-12-21 2002-01-29 Gramineer Internat Ab New composition, methods and use
PL368572A1 (en) * 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
US20090005437A1 (en) * 2004-08-09 2009-01-01 Eyal Gottlieb Alpha-Ketoglutarates and Their Use as Therapeutic Agents
CN101065121A (en) * 2004-10-20 2007-10-31 寿制药株式会社 Therapeutic or preventive composition for gastric mucosa disease
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion

Also Published As

Publication number Publication date
CN104825433A (en) 2015-08-12
JP2010532347A (en) 2010-10-07
KR101610791B1 (en) 2016-04-11
CN102014888A (en) 2011-04-13
KR20100053546A (en) 2010-05-20
JP2014193866A (en) 2014-10-09
WO2009005379A1 (en) 2009-01-08
KR20150003908A (en) 2015-01-09
JP5518702B2 (en) 2014-06-11

Similar Documents

Publication Publication Date Title
IL203051A (en) Use of alpha-ketoglutarate for the preparation of medicaments
IL226702A (en) Therapeutic isoxazole compounds for the preparation of medicaments
HK1211889A1 (en) Therapeutic use of diaminophenothiazines
EP2211620A4 (en) Therapeutic compounds
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
IL210549A (en) Substituted- quinoxaline-type bridged-piperidine compounds, compositions comprising them and uses thereof for the manufacture of medicaments
GB0813087D0 (en) Therapeutic compounds
GB0716532D0 (en) Therapeutic compounds
EP2164324A4 (en) Therapeutic compounds
ZA200907191B (en) Process for the preparation of gefitiib
GB0721332D0 (en) Medicaments
HK1161555A1 (en) Use of an antiprolactinic veterinary composition for the manufacture of a medicament
IL199697A0 (en) Therapeutical uses of eslicarbazepine
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
EP2185568A4 (en) Therapeutic compounds
HUP0700756A2 (en) Process for the preparation of pharmaceutical intermediers
EP2157089A4 (en) The therapeutic uses of imidazol-5-carboxylic acid derivatives
GB2464854B (en) Process for the preparation of risperidone
GB0702862D0 (en) Therapeutic compounds
GB0717450D0 (en) Medicament
GB0721333D0 (en) Medicaments
SI2219611T1 (en) Pharmaceutical forms for the release of active compounds
GB0708188D0 (en) Therapeutic compounds
GB0711886D0 (en) Therapeutic compounds
GB0717573D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees